Biodesix, Inc. (BDSX) vs Profound Medical Corp. (PROF)
A side-by-side comparison of Biodesix, Inc. and Profound Medical Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDSX
Biodesix, Inc.
$28.15HealthcareDelayed quote: Oct 6, 2026, 2:39 PM EDT
PROF
Profound Medical Corp.
$6.13HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
Total return — BDSX vs PROF
growth of $100 · dividends reinvested · last 6yBDSX -88.7% (-30.4%/yr)PROF -65.1% (-16.1%/yr)PROF compounded faster over this window
BDSX PROF
BDSX vs PROF: by the numbers
- •BDSX is the larger company ($229M vs $223M market cap).
- •Both run net losses; BDSX's is the smaller (-26.97% vs -171.72% net margin).
- •PROF grew revenue faster over the past five years (16.55% vs 5.99% CAGR).
Metrics side by side
Valuation
| Metric | BDSX | PROF |
|---|---|---|
| P/S ratio | 2.23 | 11.71 |
| P/B ratio | 25.06 | 4.47 |
Profitability
| Metric | BDSX | PROF |
|---|---|---|
| Gross margin | 82.50% | 71.79% |
| Operating margin | -31.37% | -256.27% |
| Net margin | -26.97% | -171.72% |
| ROE | -303.61% | -65.59% |
| ROIC | -25.73% | -61.03% |
Growth (annualized)
| Metric | BDSX | PROF |
|---|---|---|
| Revenue CAGR (5Y) | 5.99% | 16.55% |
| Total return CAGR (5Y) | -28.49% | -15.23% |
Frequently asked
- Which has grown faster, BDSX or PROF?
- Over the past five years, PROF grew revenue faster — BDSX at a 5.99% CAGR versus PROF at 16.55%.
- How have BDSX and PROF total returns compared?
- Over the past 5 years, BDSX delivered -28.49% and PROF delivered -15.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Biodesix ROEProfound Medical ROEBiodesix operating marginProfound Medical operating marginBiodesix revenue growthProfound Medical revenue growthBiodesix free cash flowProfound Medical free cash flow
Biodesix & Profound Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.